Pliant Therapeutics, Inc. (PLRX)
NASDAQ: PLRX · Real-Time Price · USD
1.120
+0.030 (2.75%)
Jul 15, 2026, 4:00 PM EDT - Market closed
Pliant Therapeutics Market Cap
Pliant Therapeutics has a market cap or net worth of $68.82 million as of July 16, 2026. Its market cap has decreased by -3.35% in one year.
Market Cap
68.82M
Enterprise Value
-73.28M
1-Year Change
-3.35%
Ranking
Category
Stock Price
$1.12
Market Cap Chart
Since June 3, 2020, Pliant Therapeutics's market cap has decreased from $737.62M to $68.82M, a decrease of -90.67%. That is a compound annual growth rate of -32.14%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 15, 2026 | 68.82M | -8.20% |
| Dec 31, 2025 | 74.97M | -90.65% |
| Dec 31, 2024 | 801.44M | -26.12% |
| Dec 29, 2023 | 1.08B | 15.09% |
| Dec 30, 2022 | 942.52M | 93.72% |
| Dec 31, 2021 | 486.53M | -39.64% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 3, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Gain Therapeutics | 75.07M |
| Annovis Bio | 74.87M |
| OS Therapies | 72.15M |
| iBio, Inc. | 72.03M |
| XBiotech | 71.04M |
| Gossamer Bio | 70.44M |
| MindWalk Holdings | 70.03M |
| ImageneBio | 68.92M |